Swiss National Bank’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.95M | Sell |
41,200
-1,300
| -3% | -$133K | ﹤0.01% | 1571 |
|
|
2026
Q1 | $4.64M | Hold |
42,500
| – | – | ﹤0.01% | 1403 |
|
|
2025
Q4 | $3.45M | Buy |
42,500
+900
| +2% | +$77.5K | ﹤0.01% | 1578 |
|
|
2025
Q3 | $3.64M | Buy |
41,600
+2,800
| +7% | +$250K | ﹤0.01% | 1503 |
|
|
2025
Q2 | $3.22M | Sell |
38,800
-400
| -1% | -$33.4K | ﹤0.01% | 1529 |
|
|
2025
Q1 | $3.29M | Sell |
39,200
-600
| -2% | -$55.8K | ﹤0.01% | 1496 |
|
|
2024
Q4 | $3.67M | Buy |
39,800
+300
| +0.8% | +$28.9K | ﹤0.01% | 1504 |
|
|
2024
Q3 | $3.67M | Hold |
39,500
| – | – | ﹤0.01% | 1504 |
|
|
2024
Q2 | $3.25M | Hold |
39,500
| – | – | ﹤0.01% | 1544 |
|
|
2024
Q1 | $2.62M | Hold |
39,500
| – | – | ﹤0.01% | 1691 |
|
|
2023
Q4 | $2.24M | Sell |
39,500
-4,400
| -10% | -$230K | ﹤0.01% | 1768 |
|
|
2023
Q3 | $2.39M | Buy |
43,900
+500
| +1% | +$29.6K | ﹤0.01% | 1723 |
|
|
2023
Q2 | $2.92M | Buy |
43,400
+700
| +2% | +$42.7K | ﹤0.01% | 1643 |
|
|
2023
Q1 | $2.2M | Sell |
42,700
-5,000
| -10% | -$243K | ﹤0.01% | 1786 |
|
|
2022
Q4 | $2.2M | Buy |
47,700
+900
| +2% | +$42.1K | ﹤0.01% | 1834 |
|
|
2022
Q3 | $2.37M | Buy |
46,800
+300
| +0.6% | +$15K | ﹤0.01% | 1746 |
|
|
2022
Q2 | $2.12M | Hold |
46,500
| – | – | ﹤0.01% | 1871 |
|
|
2022
Q1 | $2.16M | Buy |
46,500
+3,600
| +8% | +$161K | ﹤0.01% | 1992 |
|
|
2021
Q4 | $2.15M | Buy |
42,900
+2,000
| +5% | +$103K | ﹤0.01% | 2008 |
|
|
2021
Q3 | $2.17M | Buy |
40,900
+500
| +1% | +$28.2K | ﹤0.01% | 1999 |
|
|
2021
Q2 | $2.46M | Buy |
40,400
+900
| +2% | +$47.8K | ﹤0.01% | 1965 |
|
|
2021
Q1 | $1.93M | Buy |
39,500
+600
| +2% | +$28.1K | ﹤0.01% | 2026 |
|
|
2020
Q4 | $1.57M | Hold |
38,900
| – | – | ﹤0.01% | 2048 |
|
|
2020
Q3 | $1.26M | Buy |
38,900
+1,000
| +3% | +$30K | ﹤0.01% | 1957 |
|
|
2020
Q2 | $1M | Buy |
37,900
+4,900
| +15% | +$128K | ﹤0.01% | 2100 |
|
|
2020
Q1 | $822K | Buy |
33,000
+700
| +2% | +$21.6K | ﹤0.01% | 1941 |
|
|
2019
Q4 | $1.16M | Buy |
32,300
+1,300
| +4% | +$44.9K | ﹤0.01% | 2055 |
|
|
2019
Q3 | $1.06M | Hold |
31,000
| – | – | ﹤0.01% | 2028 |
|
|
2019
Q2 | $867K | Buy |
31,000
+700
| +2% | +$19.5K | ﹤0.01% | 2189 |
|
|
2019
Q1 | $939K | Buy |
30,300
+1,000
| +3% | +$26.7K | ﹤0.01% | 2092 |
|
|
2018
Q4 | $693K | Sell |
29,300
-800
| -3% | -$21.8K | ﹤0.01% | 2209 |
|
|
2018
Q3 | $1.17M | Hold |
30,100
| – | – | ﹤0.01% | 2059 |
|
|
2018
Q2 | $1.01M | Buy |
30,100
+3,500
| +13% | +$125K | ﹤0.01% | 2156 |
|
|
2018
Q1 | $964K | Buy |
26,600
+1,700
| +7% | +$58.9K | ﹤0.01% | 2098 |
|
|
2017
Q4 | $793K | Hold |
24,900
| – | – | ﹤0.01% | 2222 |
|
|
2017
Q3 | $932K | Hold |
24,900
| – | – | ﹤0.01% | 2100 |
|
|
2017
Q2 | $777K | Buy |
+24,900
| New | +$719K | ﹤0.01% | 2199 |
|
Other funds holding LMAT
CCA
CAM
CCM
Swiss National Bank's LMAT Position: Q2 2026 in Review
Swiss National Bank reduced its LeMaitre Vascular (LMAT) stake by 3.1% in Q2 2026, selling an estimated $133K and leaving 41,200 shares worth $3.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1571.
Swiss National Bank first reported a position in LMAT in Q2 2017 and has held it in 37 quarters since. The position peaked at $4.64M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Swiss National Bank held 41,200 shares of LeMaitre Vascular worth $3.95M as of Q2 2026.
- Swiss National Bank sold 1,300 LeMaitre Vascular shares in Q2 2026, an estimated $133K.
- LeMaitre Vascular made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1571 holding.
- Swiss National Bank first reported a position in LeMaitre Vascular in Q2 2017 and has held it in 37 quarters since.
- Swiss National Bank's LeMaitre Vascular position peaked at $4.64M in Q1 2026.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.